Towards Healthcare
Oncology Drugs Market to Lead USD 360.79 Bn by 2034

Oncology Drugs Market Driven by Targeted Therapies

According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, as poor lifestyle, longer working period, progressively stressful lives, alcohol consumption, smoking, increasing use of contraception, nulliparity, and reduced breastfeeding are all contributing to increasing cancer cases. North America is dominant in the market due to increasing R&D investment and a strong regulatory environment.

Content

  • Last Updated: 24 September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The oncology drugs market stands at USD 217.18 billion in 2025 and is expected to reach USD 360.79 billion by 2034, growing at a CAGR of 6.29% from 2024 to 2034.

North America is currently leading the oncology drugs market share by 40% due to advanced healthcare infrastructure and the presence of major healthcare players.

The oncology drugs market includes five segments: by drug class, by indication, by therapy type, by distribution channel, and by region.

Oncology drugs are medications used to diagnose, treat, and manage cancer by targeting and controlling the growth and spread of abnormal cells.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions